Thermo Fisher Scientific
No matter what your stage of research, you can find the resources and learning materials you need to overcome obstacles and advance your cell therapy knowledge.
Our Thermo Fisher Scientific specialists take you through what you need to consider when setting up a commercial strategy for success.
Cell therapy manufacturing leaders discuss the challenges of commercializing cell therapies. Learn how manufacturing innovations, industry partnerships, and more can help you optimize your processes and accelerate your commercialization journey.
Learn how PACT Pharma Inc. revolutionized a nonviral precision genome engineering process through automation and standardization of the end-to-end cell therapy manufacturing workflow.
Learn how emerging technologies in cell therapy manufacturing can enable automation and standardization.
Tune into this webinar and learn all about the drivers and challenges of decentralized manufacturing from industry leaders.
Watch this webinar to learn about the challenges associated with supporting conversion of autologous to allogeneic workflows.
Learn why implementing Good Manufacturing Practices (GMP) is critical to ensure consistent quality and safety of any pharmaceutical product.
In this webinar, we uncover three key areas to consider when you’re preparing to commercialize a cell therapy.
Learn how the new state-of-the-art cell therapy manufacturing and collaboration center will empower researchers to scale future clinical campaigns.
When his lymphoma grew faster than expected, Paul Chae was treated with CAR-T cell therapy. Discover how innovations in technology helped Paul become cancer free.
Cell and gene therapy industry experts come together to discuss how the lessons learned from biologics can be applied to advance the industrialization of cell therapy manufacturing.
Realize your vision of transforming cells into life-saving cell therapies.
This article reviews the considerations and benefits of an automated closed, modular cell therapy workflow.
In this article, cell therapy manufacturing leaders from PACT Pharma Inc. and Thermo Fisher Scientific discuss safety and regulatory advantages of non-viral transfection for cell therapy and scaling and automating the manufacturing process.
Whether you’re new to cell therapy manufacturing or looking to expand your existing processes and knowledge base, this article highlights emerging technologies for cell therapy manufacturers.
The journey of the patient from vein-to-vein is a complex process that requires a multitude of products, instrumentation, equipment and regulatory compliant infrastructure.
Navigate top manufacturing challenges and solutions across the autologous T-cell therapy workflow.
Download our infoposter to learn more about the development of cell therapies, historical breakthroughs, common challenges, and things to consider through each stage of the workflow.
A review of the latest methodologies, common practices, resources, applications and more, to support every step of your cell therapy manufacturing workflow.
The patient is at the center of the cell therapy journey. Discover how a GMP-compliant, semiautomated manufacturing platform can result in consistent, efficacious CAR T cell production.
Learn how you can integrate complex workflows to improve the consistency, purity, and safety of your CAR-T cell product.
Get a step-by-step guide for T cell isolation and activation with Gibco CTS Dynabeads using the Gibco CTS Rotea system and Gibco CTS DynaMag Magnet.
Discover why the quality of raw materials needs to be considered according to the stage of development of the cell or gene therapy.
Learn about the technological innovations impacting the urgent needs in cell and gene therapy development.
From discovery to cell therapy bioprocessing and commercialization, Thermo Fisher Scientific is the partner to support you at every step of the way.
Find out how Thermo Fisher Scientific can connect you to Cell and Gene Therapy products, services and solutions to help you progress.
Download our case study to learn how the Biopharmaceutical Analysis Training Laboratory (BATL) at Northeastern University created efficiencies in cell and gene therapy manufacturing by collaborating with Thermo Fisher Scientific as a single partner.
Discover why collaboration matters, what makes a good partnership, and how you can overcome the challenges of cell therapy manufacturing and scaling on your path to clinical and commercial success.
Whether you’re a large biotech company producing blockbuster therapeutics or a startup biotech looking to bring your innovative and disruptive product to market, this blog post will show you how partnership can help you accelerate cell therapy development—and avoid headaches along the way.
Discover how to reduce the contamination risk, maintain environmental stability, and reduce gas use and evaporation with Thermo Fisher Scientific Cell Locker™ System.
Translating innovative cell therapy research into promising products requires the use of carefully controlled incubation environments that provide optimal conditions for cell growth.
Learn how an electronically monitored BSC can provide a strong link in the aseptic processing chain, maintaining safety and quality, and simplifying the compliance process.
New GMP-focused laboratory solutions are easing the transition from cell and gene therapy research to GMP production.
Learn how real-time supervision of critical laboratory equipment parameters can boost laboratory efficiency and productivity by reducing sample failures.
The cell therapy commercialization process doesn’t have to be daunting. Learn to how to make it easier by relying on cell therapy solutions and expert advice.
Discoveries in gene and cell therapies are happening every day. Learn how to achieve seamless transitions from the discovery to the production phase by using a controlled-rate freezer.
Researchers face enormous pressure in maintaining their adherence to cGMP standards. Discover how Thermo Fisher Scientific focuses on simplifying cGMP compliance.
Don't have an account ?